European scaleups are becoming more deliberate about how they finance growth. Equity remains central, but it is increasingly being combined with venture debt, growth credit, strategic capital and internal cash generation. The change reflects a more mature financing market in which companies are optimising for dilution, flexibility and resilience rather than relying on a single source of capital.

Equity is well suited to financing uncertain, high-risk growth, but it can be expensive when a company has already created substantial enterprise value. Scaleups with recurring revenue and clearer financial visibility have more choices than early-stage startups. They can evaluate whether a funding need genuinely requires risk capital or whether debt, working-capital facilities or other instruments can finance it more efficiently. This does not make equity less important. It means companies can be more selective about when they use it and how much ownership they exchange.

Venture debt can extend runway after an equity financing or fund specific growth initiatives without requiring another immediate priced round. For companies with strong investor backing and predictable revenue, this can provide useful flexibility. The benefit is greatest when management has a clear view of what the additional capital will achieve and how the debt will ultimately be repaid or refinanced. Used well, venture debt can improve capital efficiency. Used simply to delay difficult decisions, it can increase risk.

As technology companies mature, a broader range of private credit and growth lending products becomes available. Businesses with meaningful revenue, stronger margins or a path to profitability may be able to raise larger facilities than traditional venture debt would provide. These structures can support acquisitions, geographic expansion or shareholder liquidity. The trade-off is that lenders typically expect more financial discipline and may require stronger covenants or security. Scaleups therefore need to assess financing capacity in the context of their broader operating plan.

Corporate and strategic investors can provide capital alongside commercial relationships, distribution or access to new markets. For some scaleups, this can be particularly attractive when the investor’s strategic value reduces execution risk. The downside is that strategic capital can affect future optionality if competitors perceive the company as aligned with one ecosystem. Management teams should therefore assess not only valuation and funding amount, but also the commercial rights, information rights and strategic implications attached to the investment.

Improving operating efficiency gives scaleups another source of financing: their own cash flow. A business that can fund a greater share of growth internally becomes less dependent on external markets and can choose when to raise rather than being forced to do so. This does not require abandoning growth. It requires understanding which investments generate attractive returns and where spending can be reduced without damaging momentum. Stronger cash generation can also improve access to debt and strengthen negotiating leverage with equity investors.

The most important change is that financing is becoming a portfolio decision. Scaleups can combine different forms of capital according to the risk, duration and return profile of each use of funds. Equity may finance product expansion, debt may support working capital or acquisitions, and internally generated cash may fund recurring investment. This approach requires more financial planning, but it can reduce dilution and improve resilience. The optimal structure will differ by company, but the principle is increasingly consistent: match the source of capital to the purpose it serves.